Your browser doesn't support javascript.
loading
A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis.
Carter, Melody C; Maric, Irina; Brittain, Erica H; Bai, Yun; Lumbard, Keith; Bolan, Hyejeong; Cantave, Daly; Scott, Linda M; Metcalfe, Dean D.
Afiliação
  • Carter MC; Mast Cell Biology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. Electronic address: mcarter@niaid.nih.gov.
  • Maric I; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Md.
  • Brittain EH; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda; Md.
  • Bai Y; Mast Cell Biology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Lumbard K; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Md.
  • Bolan H; Mast Cell Biology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Cantave D; Department of Nursing, Clinical Center, National Institutes of Health, Bethesda, Md.
  • Scott LM; Mast Cell Biology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Metcalfe DD; Mast Cell Biology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
J Allergy Clin Immunol ; 147(3): 1004-1010.e2, 2021 03.
Article em En | MEDLINE | ID: mdl-33220353
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antialérgicos / Omalizumab / Hipersensibilidade / Anafilaxia Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antialérgicos / Omalizumab / Hipersensibilidade / Anafilaxia Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2021 Tipo de documento: Article